Back
Nektar Therapeutics Stock Price Chart

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
37
NKTR
Nektar Therapeutics
Last Price:
$0.59
Seasonality Move:
-2.46%
7 Day Trial
ALL ACCESS PASS
$
7

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.
Nektar Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.68 | Sell |
20-day SMA: | 0.68 | Sell |
50-day SMA: | 0.73 | Sell |
200-day SMA: | 1.03 | Sell |
8-day EMA: | 0.65 | Sell |
20-day EMA: | 0.68 | Sell |
50-day EMA: | 0.73 | Sell |
200-day EMA: | 0.94 | Sell |
Nektar Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 39.02 | Sell |
Chaikin Money Flow: | -1021170 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.55 - 0.73) | Sell |
Bollinger Bands (100): | (0.67 - 0.97) | Sell |
Nektar Therapeutics Technical Analysis
Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Nektar Therapeutics Stock
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 0.59 while NKTR 8-day simple moving average is 0.68, which is a Sell signal.
-
The stock price of NKTR is 0.59 while Nektar Therapeutics 20-day SMA is 0.68, which makes it a Sell.
-
Nektar Therapeutics 50-day simple moving average is 0.73 while NKTR share price is 0.59, making it a Sell technically.
-
NKTR stock price is 0.59 and Nektar Therapeutics 200-day simple moving average is 1.03, creating a Sell signal.
NKTR Technical Analysis vs Fundamental Analysis
Sell
37
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a SellThe current Nektar Therapeutics [NKTR] share price is $0.59. The Score for NKTR is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Nektar Therapeutics Stock Info
Market Cap:
109.6M
Price in USD:
0.59
Share Volume:
1.9M
Nektar Therapeutics 52-Week Range
52-Week High:
1.93
52-Week Low:
0.43
Sell
37
Nektar Therapeutics (NKTR)
is a Sell
Nektar Therapeutics Share Price Forecast
-
What is the Nektar Therapeutics stock price today?The Nektar Therapeutics stock price is 0.59 USD today.
-
Will NKTR stock go up or go down?Nektar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Nektar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nektar Therapeutics is overvalued.
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 0.59 while NKTR 8-day exponential moving average is 0.65, which is a Sell signal.
-
The stock price of NKTR is 0.59 while Nektar Therapeutics 20-day EMA is 0.68, which makes it a Sell.
-
Nektar Therapeutics 50-day exponential moving average is 0.73 while NKTR share price is 0.59, making it a Sell technically.
-
NKTR stock price is 0.59 and Nektar Therapeutics 200-day simple moving average is 0.94, creating a Sell signal.
Fundamental Analysis of Nektar Therapeutics
Is Nektar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.07 per share.
Technical Analysis of Nektar Therapeutics
Should I short Nektar Therapeutics stock?
-
NKTR Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Nektar Therapeutics is a Sell
-
Nektar Therapeutics Relative Strength Index (RSI) is 39.02, which suggest Nektar Therapeutics is oversold
-
The Bollinger Bands (25) for Nektar Therapeutics is (0.55 - 0.73), which suggest Nektar Therapeutics is a Sell
-
The Bollinger Bands (100) for Nektar Therapeutics is (0.67 - 0.97), which suggest Nektar Therapeutics is a Sell
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.